PRDX5 and cancer: We found that okanin in vitro and in vivo inhibited the growth of colorectal cancer cells by directly targeting at PRDX5 to trigger both apoptosis and ferroptosis, suggesting that PRDX5 is a target of cancer chemotherapy.